Announced today that the companys highly selective oral kinase inhibitor.

Telatinib is currently in Phase 2 medical testing in the United States and in European countries for the first-line treatment of advanced gastric cancers patients in conjunction with standard-of-care chemotherapy. The company is planning Telatinib to be Phase 3 ready for first-line gastric tumor treatment by the finish of 2010, with New Drug Software submitting targeted for 2013. Telatinib is an oral little molecule medication that inhibits the VEGFR, PDGFR and Package receptor tyrosine kinases. Telatinib is selective extremely, thus eliminating off-target unwanted effects and providing the prospect of better efficacy and excellent combinability with other anti-cancer brokers.Barbara Lee throughout a special program at the International AIDS Conference here. Lee said that she and others from both relative sides of the aisle had caused ex – President George W. Bush to pass the President’s Emergency Plan for AIDS Relief , which, ‘to be honest, has saved an incredible number of lives’ . This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health Information, an editorially independent information service, is a scheduled program of the Kaiser Family Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente.

Acne Vulgaris THE FACTS Acne vulgaris may be the scientific name for pimples.